Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company"), a leader in the development of differentiated targeted radiotherapies, announced today that new preclinical data for its lead antibody ...
Advanced quantum spectroscopy at RIKEN reveals insights into antiproton properties, potentially challenging CPT invariance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback